LifeMD Q3 2026 net loss widens 23% year over year to $4.47 million

By Public Technologies21:16 (UTC), 12 November 2026 Updated

LifeMD’s third-quarter 2026 net loss from continuing operations attributable to common stockholders narrowed 38% sequentially to $5.2 million.
Revenue fell 7% year-over-year to $44.6 million, below guidance, following deliberate marketing cuts and slower-than-expected partnership ramps.
Active subscribers rose 13% year-over-year to approximately 350,000 at quarter-end.
An exclusive AT&T relationship gives its 100 million wireless and fiber customers access to healthcare and pharmacy services.
Full-year 2026 revenue guidance was cut to $188 million–$191 million; fourth-quarter revenue is expected at $46 million–$49 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeMD Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611121605PRIMZONEFULLFEED9876712) on November 12, 2026, and is solely responsible for the information contained therein.